Literature DB >> 3024832

Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.

T L Whiteside, S Miescher, J Hurlimann, L Moretta, V von Fliedner.   

Abstract

T lymphocytes were isolated from tumor biopsies in 13 patients with breast carcinomas. Immunohistology with monoclonal antibodies confirmed the presence of mononuclear cell infiltrates composed primarily of T lymphocytes in all tumors studied. While the proportion of T lymphocytes expressing the T4 or the T8 surface marker varied from tumor to tumor as determined by morphometric analysis, T8+ cells were more numerous than T4+ cells in 8/12 breast tumors studied. Relatively few T cells (less than 10% in 11/12 tumors) were in an activated state as judged by the surface expression of HLA-DR antigens or the receptor for interleukin-2 (IL-2). In 1 case 20% of the infiltrating mononuclear cells were expressing the IL-2 receptor. The tumor infiltrating lymphocytes (TIL) recovered from 10 tumors were cloned in a microculture system that permits proliferation of nearly 100% of normal peripheral blood T lymphocytes (PBL-T). In contrast to normal and autologous PBL-T, frequencies of proliferating T lymphocyte precursors (PTL-P) were depressed (less than 0.01) in 7/10 TIL preparations indicating a decreased responsiveness of TIL to phytohemagglutinin at the single-cell level. The frequency of PTL-P was noticeably higher in 2 cases (0.03 and 0.09) and close to normal in 1 case (0.39). A total of 170 clones were expanded in vitro and analyzed for different functional capabilities. Most of these clones expressed the T4+/T8-phenotype (73%) and strikingly 53% of these T4+/T8- clones were cytolytic in a lectin-dependent assay, a functional subset which is uncommon among normal PBL-T. Some clones (10%) lysed allogeneic breast tumor cells (MCF7). Only 15% of the clones displayed natural killer activity. Among the cytolytic clones, 17 of 31 tested were also IL-2 producers irrespective of the T4 or T8 phenotype. Our results show that human mammary carcinomas contain many infiltrating T cells with cytolytic potential. Interestingly, among the proliferating cytolytic T cell clones (56% of the microcultures), many expressed the T4+/T8- phenotype. These findings may indicate that the in situ cytolytic reaction (against unknown antigens) is associated preferentially with class II antigens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024832     DOI: 10.1007/BF00205646

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  40 in total

1.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

2.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

3.  Immunocompetence, immunosuppression, and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well-defined clinical stages of disease.

Authors:  J A Stein; A Adler; S B Efraim; M Maor
Journal:  Cancer       Date:  1976-09       Impact factor: 6.860

4.  Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.

Authors:  B M Vose; F Vánky; E Klein
Journal:  Int J Cancer       Date:  1977-12-15       Impact factor: 7.396

5.  Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors.

Authors:  P M Moy; E C Holmes; S H Golub
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

6.  Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.

Authors:  A K Bhan; C L DesMarais
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

7.  Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascitic fluid. Phenotypic and functional characterization of T-cell clones capable of lysing autologous carcinoma cells.

Authors:  S Ferrini; R Biassoni; A Moretta; M Bruzzone; A Nicolin; L Moretta
Journal:  Int J Cancer       Date:  1985-09-15       Impact factor: 7.396

8.  Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site.

Authors:  B M Vose
Journal:  Int J Cancer       Date:  1982-08-15       Impact factor: 7.396

9.  Possible host resistance in carcinoma of the breast: a histological study.

Authors:  I M Hamlin
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

10.  Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity.

Authors:  O Eremin; R R Coombs; J Ashby
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

View more
  23 in total

1.  Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications.

Authors:  K F Yoong; D H Adams
Journal:  Clin Mol Pathol       Date:  1996-10

2.  Tumor-infiltrating lymphocytes from nonrenal urological malignancies.

Authors:  G P Haas; D Solomon; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer.

Authors:  R Bilik; C Mor; B Hazaz; C Moroz
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors.

Authors:  Y Shimizu; S Iwatsuki; R B Herberman; T L Whiteside
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

5.  In situ cytokine production by breast cancer tumor-infiltrating lymphocytes.

Authors:  B J Camp; S T Dyhrman; V A Memoli; L A Mott; R J Barth
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

6.  Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates.

Authors:  Alessandra Estrela-Lima; Márcio S S Araújo; João M Costa-Neto; Andréa Teixeira-Carvalho; Stella M Barrouin-Melo; Sergio V Cardoso; Olindo A Martins-Filho; Rogéria Serakides; Geovanni D Cassali
Journal:  BMC Cancer       Date:  2010-06-04       Impact factor: 4.430

7.  Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing mice.

Authors:  I H Ames; G M Gagne; A M Garcia; P A John; G M Scatorchia; R H Tomar; J G McAfee
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

8.  Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes.

Authors:  C J Punt; J A Barbuto; H Zhang; W J Grimes; K D Hatch; E M Hersh
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

9.  Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye.

Authors:  T L Knisely; J Y Niederkorn
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

10.  Study of the relationship between immunohistologically demonstrated lymphocytes infiltrating human breast carcinomas and patients' survival.

Authors:  H O Wintzer; W Bohle; S von Kleist
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.